Kenneth H Paulus bought TDOC once, on Nov 14, 2025
Director at Teladoc Health, Inc.
SEC CIK 0001624004 · Filings on SEC.gov ↗
Kenneth H Paulus's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
2 filings since Jun 2020, newest first
About Kenneth H Paulus
Kenneth H. Paulus is a healthcare executive and corporate director who serves as a non‑executive chairman and director at Teladoc Health, Inc.( He joined Teladoc Health’s board of directors in February 2017 and has held key governance roles, including service on the Nominating & Corporate Governance and Quality & Safety committees, helping oversee the company’s strategic direction in virtual care and digital health( Paulus has also been noted as a significant shareholder and insider through his equity transactions in Teladoc Health stock(
Paulus previously served as President and CEO of Allina Health from 2009 to 2014, leading one of the nation’s largest not‑for‑profit integrated delivery systems, and earlier as President and COO at Allina Health( Before that, he was President and CEO of Atrius Health and COO of Partners Community HealthCare/Partners HealthCare, both major integrated physician organizations and teaching affiliates of Harvard Medical School( He later became President and CEO of Prime Therapeutics, a large pharmacy benefit manager, and has held multiple board roles at healthcare companies including Gravie and Breg( Paulus earned a Bachelor of Arts in biology from Augustana College and a Master of Healthcare Administration from the University of Minnesota, providing the academic foundation for his long career in healthcare leadership and corporate governance(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.